MacroGenics, Inc.MGNXNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P50
Within normal range
vs 2Y Ago
-12.5x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM-43.93%-13.6%
2024-38.67%-1196.6%
20233.53%+104.9%
2022-71.92%+71.5%
2021-252.31%-107.1%
2020-121.83%+54.2%
2019-265.83%+1.4%
2018-269.53%-3280.9%
2017-7.97%+86.4%
2016-58.81%-